Share Price:

APNASPENAspen Pharmacare Hldgs21994-36 (-0.16%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Quality of S-26 in South Africa Guaranteed

Johannesburg: Aspen Nutritionals, manufacturer of S-26 and other infant milk formulations (IMFs), confirms that all IMFs manufactured and marketed by Aspen Nutritionals are safe for infant consumption.

This statement is being issued in response to a media report concerning the Tanzanian Food and Drug Administration’s withdrawal notification of a consignment of S-26, which, until proven otherwise, could be counterfeit product.

Karyn Purchase, Aspen Nutritionals Factory Manager said, “S-26 has been manufactured in South Africa for the past 40 years without any adverse incident being recorded. S-26 and all other IMFs sold by Aspen on the South African market are tested to the highest international standards, meeting not only the latest South African Foodstuffs, Cosmetics and Disinfectants Act and regulations (ACT 54: 1972), but also CODEX / WHO standards applicable to IMFs and Follow-On formulations, FDA CFR21 (applicable legislation “Infant Formula Quality Control Procedures). Aspen’s IMFs have always met all International Quality and Food Safety requirements”.

Aspen’s Clayville Facility, which manufactures IMFs, is GMP and HACCP certified through the Perishable Products Export Control Board (PPECB), which is accredited with the South African National Accreditation System (SANAS).

Up to sixty individual tests including physical, sensorial, chemical and microbiological testing is performed on every single batch number of IMFs sold by Aspen to ensure that the food safety of our customers is protected 100%.

Additionally a complete stability programme is in place to ensure continued suitability and safety, and efficacy of all IMF products up to the shelf life of each product.

Independent complete testing of all IMFs to monitor proficiency of local quality control operations is routinely conducted. Testing includes contaminants and residues testing including Melamine and Radionuclides to comply with all local and International guidelines.

Issued by: Shauneen Beukes, Shauneen Beukes Communications
Tel: (012) 661-8467 : Cell: 082 389 8900

On Behalf Of: Karyn Purchase, Aspen Nutritionals Factory Manager
Tel: (011) 206-9510 : Cell: 083 625 0810

Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.